Skip to main content
Skip to main content
LANZ logo

Lancer Orthodontics, Inc. (LANZ)

$0.04 +$0.00 (+0.00%) |CouncilHOLD · 49 · C
Bottom line: HOLD — our Council read (49/100) and AI Score (49/100) broadly agree.
MCap: 110K| Vol: 8.1K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Lancer Orthodontics, Inc. (LANZ) trades at $0.04 with AI Score 49/100 (Grade C). Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists globally. Market cap: $110,352, Sector: Healthcare.

Price live · AI analysis from Mar 18, 2026
Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists globally. The company offers a comprehensive range of orthodontic supplies, including brackets, adhesives, and instruments.

Analyst Coverage for LANZ: LANZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LANZ against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 49/100 · C

LANZ: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Lancer Orthodontics, Inc. (LANZ) Healthcare & Pipeline Overview

CEOCathy Wyss
Employees134
HeadquartersVista, US
IPO Year1986

Lancer Orthodontics, Inc., founded in 1967, provides a comprehensive suite of orthodontic products to dental professionals worldwide. With a focus on brackets, adhesives, and instruments, the company serves a global market, maintaining a niche position within the broader medical instruments and supplies sector, evidenced by its P/E ratio of 2.21 and 0.5% profit margin.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

What Is the Investment Thesis for LANZ?

Lancer Orthodontics, Inc. presents a focused investment case centered on its established position in the orthodontic supplies market. The company’s comprehensive product range and long-standing history since 1967 provide a stable foundation. Key value drivers include maintaining its existing customer base and potentially expanding its product offerings. A P/E ratio of 2.21 suggests possible undervaluation relative to earnings, though the low 0.5% profit margin warrants careful consideration. Growth catalysts involve expanding into new geographic markets or introducing innovative products. Potential risks include competition from larger players in the medical instruments and supplies sector and the challenges of navigating the OTC market. Investors should carefully assess the company's financial performance, growth strategies, and risk factors before making any investment decisions.

Based on FMP financials and quantitative analysis

LANZ Key Highlights

  • Lancer Orthodontics, Inc. was founded in 1967, demonstrating a long-standing presence in the orthodontic supplies market.
  • The company offers a comprehensive range of orthodontic products, including brackets, adhesives, wires, and instruments.
  • Lancer Orthodontics serves a global market, catering to orthodontists and dentists worldwide.
  • The company's P/E ratio is 2.21, which may indicate potential undervaluation.
  • The company's gross margin is 31.5%.

Who Are LANZ's Competitors?

LANZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NYXH Nyxoah S.A. $1.75 +1.74% $69.31M 69
KMTS Kestra Medical Technologies, Ltd. $27.70 +2.67% $1.62B 67
ZTEK Zentek Ltd. $0.46 +2.88% $49.90M 63
OMIC Singular Genomics Systems, Inc. $20.01 +0.00% $50.77M 61
BLMHF Bloom Health Partners Inc. $0.11 +0.00% $5.22M 51
FSPKF Fisher & Paykel Healthcare Corporation Limited $22.52 +0.00% $13.23B 51
CZMWY Carl Zeiss Meditec AG $32.76 +3.56% $2.87B 51
STAA STAAR Surgical Company $27.45 -1.21% $1.37B 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are LANZ's Key Strengths?

  • Long-standing presence in the market since 1967.
  • Comprehensive product range covering various orthodontic needs.
  • Global customer base providing revenue diversification.
  • Specialized focus on orthodontics, allowing for deep expertise.

What Are LANZ's Weaknesses?

  • Small market capitalization of 110K, limiting access to capital.
  • Low profit margin of 0.5%, indicating potential operational inefficiencies.
  • OTC market listing, which may deter some institutional investors.
  • Limited brand recognition compared to larger competitors.

What Could Drive LANZ Stock Higher?

  • Potential expansion into new geographic markets, such as Asia-Pacific and Latin America.
  • Introduction of innovative orthodontic products, such as advanced bracket systems and digital solutions.
  • Strategic partnerships with dental clinics, universities, and research institutions.
  • Enhanced digital marketing and e-commerce presence to reach a wider audience.
  • Focus on value-added services and training programs for orthodontists and dentists.

What Are the Key Risks for LANZ?

  • Financial-distress signal — its Altman Z-Score of 1.78 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Competition from larger, more established medical device companies.
  • Stringent regulatory requirements and compliance costs.
  • Economic downturns affecting consumer spending on elective orthodontic procedures.
  • Technological advancements rendering existing products obsolete.
  • Risks associated with trading on the OTC market, including limited liquidity and disclosure.

What Are the Growth Opportunities for LANZ?

  • Expansion into Emerging Markets: Lancer Orthodontics can pursue growth by expanding its presence in emerging markets, particularly in Asia-Pacific and Latin America. These regions are experiencing rapid economic growth and increasing demand for orthodontic treatments. By establishing distribution partnerships and tailoring its product offerings to meet local needs, Lancer Orthodontics can tap into these high-growth markets. The global orthodontics market is projected to reach billions of dollars by 2028, offering significant opportunities for expansion.
  • Product Innovation and Development: Investing in research and development to introduce innovative orthodontic products can drive growth. This includes developing advanced bracket systems, biocompatible materials, and digital solutions for treatment planning and monitoring. By staying at the forefront of technological advancements, Lancer Orthodontics can attract new customers and gain a competitive edge. The market for advanced orthodontic materials is expected to grow substantially over the next five years.
  • Strategic Partnerships and Acquisitions: Forming strategic partnerships with dental clinics, universities, and research institutions can enhance Lancer Orthodontics' market reach and product development capabilities. Acquiring smaller orthodontic suppliers can also expand the company's product portfolio and customer base. These partnerships can provide access to new technologies, distribution channels, and market insights. The mergers and acquisitions activity in the medical device industry remains robust, presenting opportunities for strategic growth.
  • Enhancing Digital Marketing and E-Commerce Presence: Strengthening its digital marketing efforts and e-commerce platform can enable Lancer Orthodontics to reach a wider audience and improve customer engagement. This includes optimizing its website for search engines, leveraging social media marketing, and offering online ordering and support services. A strong online presence can enhance brand awareness, generate leads, and drive sales. The global e-commerce market is experiencing double-digit growth, creating opportunities for online sales expansion.
  • Focus on Value-Added Services and Training: Offering value-added services, such as training programs and technical support, can differentiate Lancer Orthodontics from its competitors and enhance customer loyalty. Providing comprehensive training on its products and treatment techniques can help orthodontists and dentists achieve better clinical outcomes. These services can also generate additional revenue streams and strengthen customer relationships. The demand for continuing education and professional development in the dental industry is growing, presenting opportunities for value-added services.

What Opportunities Does LANZ Have?

  • Expansion into emerging markets with growing demand for orthodontic treatments.
  • Product innovation and development of advanced orthodontic solutions.
  • Strategic partnerships and acquisitions to expand market reach and product portfolio.
  • Enhancing digital marketing and e-commerce presence to reach a wider audience.

What Threats Does LANZ Face?

  • Competition from larger, more established medical device companies.
  • Stringent regulatory requirements and compliance costs.
  • Economic downturns affecting consumer spending on elective orthodontic procedures.
  • Technological advancements rendering existing products obsolete.

What Are LANZ's Competitive Advantages?

  • Established reputation since 1967.
  • Comprehensive product range.
  • Global customer base.
  • Specialized focus on orthodontics.

What Does LANZ Do?

Lancer Orthodontics, Inc., established in 1967, specializes in the design, manufacture, and marketing of orthodontic products. Catering to orthodontists and dentists across the globe, Lancer Orthodontics offers a comprehensive portfolio of products essential for orthodontic treatment. These include aesthetic brackets, standard brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and various other miscellaneous products. Based in Vista, California, the company has built a reputation for providing a wide array of orthodontic solutions. Lancer Orthodontics' extensive product line allows practitioners to source most, if not all, of their required materials from a single provider. This full-service approach has helped the company establish long-term relationships with its customer base. While the company's market capitalization is $0.00B, its continued operation since 1967 demonstrates its sustained presence in the orthodontic supplies market. Lancer Orthodontics focuses on delivering quality products and comprehensive solutions to meet the evolving needs of orthodontic professionals worldwide.

What Products and Services Does LANZ Offer?

  • Designs and manufactures orthodontic products.
  • Markets orthodontic products to orthodontists and dentists worldwide.
  • Offers aesthetic brackets for improved appearance.
  • Provides standard brackets and buccal tubes.
  • Supplies bands, adhesives, and wires for orthodontic procedures.
  • Offers elastomerics, intraoral, and extraoral appliances.
  • Provides instruments and miscellaneous products for orthodontic practices.

How Does LANZ Make Money?

  • Designs and manufactures a range of orthodontic products.
  • Markets and sells these products directly to orthodontists and dentists.
  • Generates revenue through product sales.

What Industry Does LANZ Operate In?

Lancer Orthodontics, Inc. operates within the medical instruments and supplies industry, a segment of the broader healthcare sector. This industry is characterized by technological advancements, stringent regulatory requirements, and increasing demand for innovative medical solutions. The global medical devices market is projected to reach trillions of dollars by 2026, driven by an aging population and rising healthcare expenditure. Lancer Orthodontics competes with both large, diversified medical device companies and smaller, specialized orthodontic suppliers. The company's success depends on its ability to offer high-quality products, maintain competitive pricing, and adapt to evolving market trends.

Who Are LANZ's Key Customers?

  • Orthodontists
  • Dentists
  • Dental clinics
  • Hospitals
AI Confidence: 69% Updated: Mar 18, 2026

ROE 1%Key Financial Metrics

Return on equity for Lancer Orthodontics, Inc. stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.7%, showing how much profit it generates from its asset base. LANZ trades at a trailing price-to-earnings ratio of 3.27, below the Healthcare sector average of ~23x. A current ratio of 5.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 30.6%, the inverse of the P/E and a quick read on earnings relative to price.

How Lancer Orthodontics, Inc. Is Valued

Lancer Orthodontics, Inc. carries a market capitalization of 110K, placing it in the micro-cap category. Relative to its peer group, LANZ's quantitative score of 49/100 is below the peer average of 62/100.

F-Score 3/9Financial Health

Lancer Orthodontics, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.78 places it in the distress zone, a signal of elevated financial risk.

LANZ Financials

Fundamental Snapshot

P/E (TTM)
3.3
Return on Equity (TTM)
+0.9%
Current Ratio
5.4

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

LANZ Latest News

No recent news available for LANZ.

LANZ Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LANZ.

Price Targets

Wall Street price target analysis for LANZ.

LANZ MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates LANZ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Cathy Wyss

CEO

Cathy Wyss serves as the CEO of Lancer Orthodontics, Inc., managing a workforce of 134 employees. Details regarding her prior experience and educational background are not available in the provided data. As CEO, she is responsible for overseeing the company's strategic direction, operational efficiency, and financial performance. Her leadership is crucial in navigating the competitive landscape of the orthodontic supplies market and driving the company's growth initiatives.

Track Record: Due to limited information, Cathy Wyss's specific achievements and strategic decisions at Lancer Orthodontics, Inc. cannot be fully assessed. Her tenure and impact on key company milestones remain unknown. Further information is needed to evaluate her track record and contributions to the company's success.

LANZ OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Lancer Orthodontics, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: As an OTC stock, Lancer Orthodontics, Inc. likely experiences lower trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. The limited liquidity may also result in greater price volatility. Investors should be aware of these challenges when trading LANZ shares on the OTC market.
OTC Risk Factors:
  • Limited financial disclosure, making it difficult to assess the company's financial health.
  • Lower trading volume and wider bid-ask spreads, leading to potential price volatility.
  • Lack of regulatory oversight compared to major exchanges.
  • Potential for fraud or manipulation due to limited transparency.
  • Higher risk of delisting or going out of business.
Due Diligence Checklist:
  • Verify the company's registration and legal status.
  • Obtain and review any available financial statements.
  • Assess the company's management team and track record.
  • Research the company's products, services, and market position.
  • Evaluate the company's competitive landscape and potential risks.
  • Understand the OTC market and its associated risks.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • Long-standing presence in the market since 1967.
  • Comprehensive product range catering to orthodontic needs.
  • Global customer base indicating market acceptance.
  • Physical headquarters in Vista, California.

Lancer Orthodontics, Inc. Healthcare Stock: Key Questions Answered

What does Lancer Orthodontics, Inc. do?

Lancer Orthodontics, Inc. specializes in the design, manufacture, and marketing of orthodontic products for orthodontists and dentists worldwide. The company offers a comprehensive range of products, including aesthetic brackets, standard brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. These products are essential for orthodontic treatment and are sold globally. Lancer Orthodontics aims to provide a complete solution for orthodontic professionals, ensuring they have access to the necessary tools and materials for effective patient care.

What do analysts say about LANZ stock?

As of 2026-03-18, there is no readily available analyst coverage or consensus on Lancer Orthodontics, Inc. (LANZ) due to its OTC listing and small market capitalization. Key valuation metrics, such as price targets and ratings, are not typically provided for companies with limited analyst following. Investors should conduct their own thorough research and due diligence before making any investment decisions. Factors to consider include the company's financial performance, growth prospects, competitive landscape, and the risks associated with trading on the OTC market.

What are the main risks for LANZ?

Lancer Orthodontics, Inc. faces several risks, including competition from larger medical device companies, stringent regulatory requirements, and economic downturns affecting consumer spending on orthodontic procedures. Additionally, technological advancements could render existing products obsolete. As an OTC-listed company, LANZ is subject to risks such as limited liquidity, disclosure, and regulatory oversight. These factors can impact the company's financial performance and stock price. Investors should carefully assess these risks before investing in LANZ.

What are the key factors to evaluate for LANZ?

Lancer Orthodontics, Inc. (LANZ) holds an AI score of 49/100 (low). Not financial advice.

How frequently does LANZ data refresh on this page?

LANZ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven LANZ's recent stock price performance?

Lancer Orthodontics, Inc. (LANZ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing presence in the market since 1967. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider LANZ overvalued or undervalued right now?

Valuing Lancer Orthodontics, Inc. (LANZ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying LANZ?

Before investing in Lancer Orthodontics, Inc. (LANZ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on the company due to its OTC listing and small market capitalization.
  • Analyst coverage and consensus are not available.
  • Financial data may not be readily accessible or up-to-date.
Data Sources

Popular Stocks